Expert hematologist/oncologists review key datasets in leukemia presented at the ASH 2022 Annual Meeting.
Supported in part by Amgen Oncology, Servier, and Takeda Oncology. Content developed independently by OncLive®.
February 14th 2023
Following the ASH 2022 Annual Meeting, hematologic oncology experts discuss updated data in acute lymphocytic leukemia.
Experts in hematologic oncology review and analyze updated data in chronic myeloid leukemia from ASH 2022.
Shared insight on recently updated data in acute myeloid leukemia following the ASH 2022 annual meeting.